Erasmus School of Health Policy & Management
Assistant professor | Health Technology Assessment (HTA)
- thielen@eshpm.eur.nl
- Room
- J8-15
- Location
- Burg. Oudlaan 50, Rotterdam
More information
Work
- Ngoc Do & Frederick W. Thielen (2023) - Cost-Effectiveness of Venetoclax Plus Obinutuzumab Versus Chlorambucil Plus Obinutuzumab for the First-Line Treatment of Adult Patients With Chronic Lymphocytic Leukemia: An Extended Societal View - Value in Health, 26 (4), 477-486 - doi: 10.1016/j.jval.2022.11.002 - [link]
- Frederick W. Thielen, Renaud J.S.D. Heine, Sibren van den Berg, Renske M.T.ten Ham & Carin A.Uyl de Groot (2022) - Towards sustainability and affordability of expensive cell and gene therapies? Applying a cost-based pricing model to estimate prices for Libmeldy and Zolgensma - Cytotherapy, 24 (12), 1245-1258 - doi: 10.1016/j.jcyt.2022.09.002 - [link]
- Frederick W. Thielen, Marie José Kersten, Pim Kuizenga, Mels Hoogendoorn, Eduardus F.M. Posthuma, Wendy B.C. Stevens, Carin A Uyl-de Groot & Hedwig M. Blommestein (2021) - Cost-effectiveness of lenalidomide plus rituximab versus rituximab monotherapy in patients with previously treated follicular lymphoma: a societal view - Expert Review of Anticancer Therapy, 21 (12), 1411-1422 - doi: 10.1080/14737140.2021.1971520 - [link]
- Renaud Heine, Frederick W. Thielen, Marc Koopmanschap, Marie José Kersten, Hermann Einsele, Ulrich Jaeger, Pieter Sonneveld, Jorge Sierra, Carin Smand & Carin A. Uyl-De Groot (2021) - Health Economic Aspects of Chimeric Antigen Receptor T-cell Therapies for Hematological Cancers: Present and Future - HemaSphere, 5 (2) - doi: 10.1097/HS9.0000000000000524 - [link]
- Frederick Thielen (2020) - Current Challenges in Health Technology Assessment: Assessing costs and cost-effectiveness of novel treatments in haemato-oncology - [link]
- J. Brouwer, V. J. Nijenhuis, R. Delewi, R. S. Hermanides, W. Holvoet, C. L.F. Dubois, P. Frambach, B. de Bruyne, G. K. van Houwelingen, J. A.S. van der Heyden, P. Toušek, F. van der Kley, I. Buysschaert, C. E. Schotborgh, B. Ferdinande, P. van der Harst, J. Roosen, J. Peper, F. W.F. Thielen, L. Veenstra, D. R.P.P. Chan Pin Yin, M. J. Swaans, B. J.W.M. Rensing, A. W.J. van't Hof, L. Timmers, J. C. Kelder, P. R. Stella, J. Baan & J. M. ten Berg (2020) - Aspirin with or without clopidogrel after transcatheter aortic-valve implantation - New England Journal of Medicine, 383 (15), 1447-1457 - doi: 10.1056/NEJMoa2017815 - [link]
- VJ Nijenhuis, J Brouwer, R Delewi, RS Hermanides, W Holvoet, CLF Dubois, P Frambach, B De Bruyne, GK van Houwelingen, JAS Van Der Heyden, P Toušek, F van der Kley, I Buysschaert, CE Schotborgh, B Ferdinande, P van der Harst, J Roosen, J Peper, Frederick Thielen, L Veenstra, DRPP Chan Pin Yin, MJ Swaans, BJWM Rensing, A van 't Hof, L Timmers, JC Kelder, P Stella, J Baan & J ten Berg (2020) - Anticoagulation with or without Clopidogrel after Transcatheter Aortic-Valve Implantation - New England Journal of Medicine, 382 (18), 1696-1707 - doi: 10.1056/NEJMoa1915152 - [link]
- Frederick Thielen, A van Dongen-Leunis, AMM Arons, JR Ladestein & PR Hoogerbrugge (2020) - Cost?effectiveness of Anti?CD19 chimeric antigen receptor T?Cell therapy in pediatric relapsed/refractory B?cell acute lymphoblastic leukemia. A societal view - European Journal of Haematology, 105 (2) - doi: 10.1111/ejh.13427 - [link]
- Frederick Thielen, Maite Houwing, Marjon Cnossen, IA Hadithy-Irgiztseva, Jan Hazelzet, Carin Uyl - de Groot, Anne de Pagter & Hedwig Blommestein (2020) - Cost of health care for paediatric patients with sickle cell disease: An analysis of resource use and costs in a European country - Pediatric Blood & Cancer, 67 (9) - doi: 10.1002/pbc.28588 - [link]
- BFM Wijnen, Frederick Thielen, S Konings, T Feenstra, M van der Gaag, W Veling, L De Haan, H Ising, M Hiligsmann, SMAA Evers, F Smit & J Lokkerbol (2019) - Designing and Testing of a Health-Economic Markov Model for Prevention and Treatment of Early Psychosis - Expert review of pharmacoeconomics & outcomes research - doi: 10.1080/14737167.2019.1632194 - [link]
- Frederick Thielen, NC Büyükkaramikli, R Riemsma, D Fayter, N Armstrong, C-Y Wei, V Huertas Carrera, K Misso, G Worthy, J Kleijnen & Isaac Corro Ramos (2018) - Obinutuzumab in Combination with Chemotherapy for the First-Line Treatment of Patients with Advanced Follicular Lymphoma - Pharmacoeconomics (Print) - doi: 10.1007/s40273-018-0740-4 - [link]
- Frederick Thielen, Hedwig Blommestein, LEM Oosten, FG Calkoen, AC Lankester, JJ Zwaginga, K Le Blanc, A Redondo, F Sánchez?Guijo, M Algeri, F (Franco) Locatelli, WE Fibbe & Carin Uyl - de Groot (2018) - Second?line treatment for acute graft?versus?host disease with mesenchymal stromal cells: A decision model. - European Journal of Haematology, 101 (5), 676-683 - doi: 10.1111/ejh.13158 - [link]
- K Ruggeri, JP Stuhlreyer, J Immonen, S Mareva, AF Paul, A Robbiani, Frederick Thielen, A Gelashvili, F Cavassini & F Naru (2018) - Policy evaluation - [link]
- LEM Oosten, MED Chamuleau, Frederick Thielen, LC de Wreede, Claire Siemes, Jeanette Doorduijn, OS Smeekes, MJ Kersten, L Hardi, JW Baars, AMP Demandt, WBC Stevens, GW Nijland, Carin Uyl - de Groot, PM Kluin, D de Jong & H Veelken (2017) - Treatment of sporadic Burkitt lymphoma in adults, a retrospective comparison of four treatment regimens - Annals of Hematology, 97 (2), 255-266 - doi: 10.1007/s00277-017-3167-7 - [link]
- Paula Speetjens, Frederick Thielen, Margreetten Have, Ron De Graaf & Filip Smit (2016) - Kindermishandeling: Economische gevolgen op lange termijn1 - Tijdschrift voor Psychiatrie, 58 (10), 706-711 - [link]
- Frederick Thielen, M Ten Have, R De Graaf, P Cuijpers, A Beekman & SMAA Evers (2016) - Long-term economic consequences of child maltreatment: a population-based study - European Child & Adolescent Psychiatry, 1-9 - doi: 10.1007/s00787-016-0850-5 - [link]
- Frederick Thielen (2016) - Entering your heart: how barely tested medical innovations find their way into clinical practice
- Frederick Thielen, GAPG van Mastrigt, LT (Laura) Burgers, WM (Wichor) Bramer, HJM Majoie, SMAA Evers & J Kleijnen (2016) - How to prepare a systematic review of economic evaluations for clinical practice guidelines: database selection and search strategy development (part 2/3) - Expert review of pharmacoeconomics & outcomes research, 16 (6), 1-17 - doi: 10.1080/14737167.2016.1246962 - [link]
- Frederick Thielen, Hedwig Blommestein & Carin Uyl - de Groot (2016) - Using appropriate methods in cost-effectiveness analyses: the case of allogeneic hematopoietic cell transplantation in sickle cell disease - Biology of Blood and Marrow Transplantation, 22 (11), 2109-2110 - doi: 10.1016/j.bbmt.2016.08.022 - [link]
- Frederick Thielen (2018) - Best Student Poster Presentation
- WF (Frederick) Thielen (2013) - ESST European Award for Aspiring Undergraduates
Dark Peak Analytics
- Start date approval
- januari 2022
- End date approval
- januari 2025
- Place
- SHEFFIELD
TriData
- Start date approval
- januari 2022
- End date approval
- januari 2025
- Place
- UTRECHT
- Description
- Teacher Statistical Programming & Data Science
Master Thesis Eu-HEM
- Level
- master
- Year Level
- master
- Year
- 2022
- Course Code
- GW4560M
Health Technology Assessment
- Year Level
- master, master, master
- Year
- 2022
- Course Code
- GW4546M
Health Technology Assessment (Eu-HEM)
- Level
- master
- Year Level
- master
- Year
- 2022
- Course Code
- GW4585M
Master Thesis HEPL
- Level
- master
- Year Level
- master
- Year
- 2022
- Course Code
- GW4555M
Master HEPL-HE 2022-2023
- Year
- 2022
- Course Code
- GWMTTHEPL
Master Thesis HE
- Year Level
- master, master
- Year
- 2022
- Course Code
- GW4592M
Pharmaceutical Pricing and Market Access
- Year Level
- master, master, master, master
- Year
- 2022
- Course Code
- GW4575M
f